MFDS, “The U.S. and Europe also exercise the conditional approval system of Phase 3 clinical trial”
It was observed there were 34 products which acquired approval with the same condition in process of Phase 3 clinical trials like the recently-issued Hanmi Pharm’s non-small cell lung cancer therapy ‘Olita Tab’
Moreover, there were other countries, such as the U.S. and Europe, which have the sam...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
